SCHEMBL8567407

SCHEMBL8567407

C=CCc1ccc(Oc2ccc(C(=O)OC)cc2)cc1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 9/20 0.46
CA1 P00915 4/20 0.45
CA2 P00918 4/20 0.45
CA12 O43570 2/20 0.45
CA7 P43166 2/20 0.45
CA9 Q16790 2/20 0.45
CA14 Q9ULX7 2/20 0.45
TP53 P04637 2/20 0.44
NPC1 O15118 1/20 0.44
MAPK1 P28482 1/20 0.44
MAPT P10636 1/20 0.44
ALDH1A1 P00352 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
ALOX12 P18054 1/20 0.44
CYP2C19 P33261 1/20 0.44
CKS1B P61024 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9151126 0.87 CA12 (0.50) PTPN1CA1CA2CA12CA7
SCHEMBL6478663 0.86 XDH (0.57) PTPN1CA1CA2CA12CA7
SCHEMBL8561742 0.79 CYP4A11 (0.55) CA1CA2CA12CA7CA9
SCHEMBL8560687 0.79 POLB (0.51) CA1CA2CA12CA7CA9
SCHEMBL542210 0.77 CA1 (0.57) PTPN1CA1CA2CA12CA7
SCHEMBL2843664 0.77 PTPN1 (0.54) PTPN1TP53NPC1ALDH1A1CYP3A4
SCHEMBL15657532 0.76 CA1 (0.59) PTPN1CA1CA2CA12CA7
SCHEMBL8561540 0.75 MAPT (0.43) PTPN1CA1CA2CA12CA7
SCHEMBL8949522 0.75 CA1 (0.80) CA1CA2CA12CA7CA9
SCHEMBL2187179 0.75 CA1 (0.80) CA1CA2CA12CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0544488-B1 Substituted phenyl phenol leukotriene antagonists LILLY CO ELI (US) 1998-03-11 EP disclosed
WO-1996036347-A1 USE OF LEUKOTRIENE ANTAGONISTS FOR ALZHEIMER'S DISEASE ELI LILLY AND COMPANY (US) 1996-11-21 WO disclosed
EP-0743064-A1 Leukotriene antagonists for use in the treatment or prevention of alzheimer's disease ELI LILLY AND COMPANY (US) 1996-11-20 EP disclosed
US-5462954-A Antiinflammatory, antiallergens; treating asthma ELI LILLY AND COMPANY (US) 1995-10-31 US disclosed
EP-0544488-A2 Substituted phenyl phenol leukotriene antagonists ELI LILLY AND COMPANY (US) 1993-06-02 EP disclosed